What is Photobiomodulation?

Big word | Powerful results

beyt_light_logo
Firefly Light Therapy™ is the latest in multi-spectrum LED light therapy, or Photobiomodulation, for pain, neurological disorders, and pathogen issues. Exciting data from current clinical studies indicate that Bales Photonics Firefly Light Therapy may be able to reverse the symptoms of central nervous system disorders like Parkinson’s and Alzheimer’s. Additionally, extensive proof exists documenting pain relieffrom all types of inflammatory diseases and injuries with the use of this multi-spectrum technology.

Combine Firefly with an F-scan and function generator and you have a powerfully accurate new way to pinpoint and potentially destroy parasites in patients suffering from a variety of auto-immune disorders and gut issues.

Firefly utilizes a powerful wave of light to penetrate the skin, tissue, and surrounding nerves to treat soft tissue injuries, reduce pain, promote wound healing, and provide therapy for chronic conditions such as arthritis and failed back syndrome. Before and after infrared images of treated areas show increased blood circulation allowing the body to heal itself without drugs or surgery

Learn More

Photobiomodulation (PBM) is Neuroprotective

Photobiomodulation and methylene blue are neuroprotective. These interventions not only reduce cellular apoptosis, but also improve the tissue healing by improving the blood flow to the tissues. Let’s review how photobiomodulation works to help mitochondria heal and function correctly.

Read More »

Patient Testimonial – Neuropathy Symptoms Decreased

Patient Linda was diagnosed with stage 3 cancer. Her doctor told her that her neuropathy would worsen and won’t be able to walk again. She met with Leigh Erin Connealy, MD and she recommended that she see Martin Bales, LAc DAOM for her neuropathy. After a couple of Firefly treatments from Dr. Bales, she can feel her feet again.

Read More »

Photobiomodulation for Alzheimer’s Disease: Has the Light Dawned?

Next to cancer, Alzheimer’s disease (AD) and dementia is probably the most worrying health problem facing the Western world today. A large number of clinical trials have failed to show any benefit of the tested drugs in stabilizing or reversing the steady decline in cognitive function that is suffered by dementia patients.

Read More »